EcoDrugPlus

60s Ribosomal Protein L15

Ensembl ID : ENSSTUG00000048344
Gene Symbol: LOC115175691
3 Cross references
352 Possible Orthologues:

60s Ribosomal Protein L15-Like

Ensembl ID : ENSSTUG00000040748
Gene Symbol: LOC115173779
3 Cross references
352 Possible Orthologues:

60s Ribosomal Protein L17

Ensembl ID : ENSSTUG00000022135
Gene Symbol: LOC115149243
3 Cross references
705 Possible Orthologues:

60s Ribosomal Protein L17-Like

Ensembl ID : ENSSTUG00000036118
Gene Symbol: LOC115159336
3 Cross references
705 Possible Orthologues:

60s Ribosomal Protein L18

Ensembl ID : ENSSTUG00000000834
Gene Symbol: LOC115189223
3 Cross references
377 Possible Orthologues:

60s Ribosomal Protein L18

Ensembl ID : ENSSTUG00000037494
Gene Symbol: LOC115176369
3 Cross references
378 Possible Orthologues:

60s Ribosomal Protein L18a

Ensembl ID : ENSSTUG00000027899
Gene Symbol: LOC115182293
3 Cross references
362 Possible Orthologues:

60s Ribosomal Protein L18a-Like

Ensembl ID : ENSSTUG00000029989
Gene Symbol: LOC115182263
3 Cross references
361 Possible Orthologues:

60s Ribosomal Protein L19

Ensembl ID : ENSSTUG00000024497
Gene Symbol: LOC115161204
3 Cross references
344 Possible Orthologues:

60s Ribosomal Protein L19-Like

Ensembl ID : ENSSTUG00000024778
Gene Symbol: LOC115171069
3 Cross references
345 Possible Orthologues:

60s Ribosomal Protein L19-Like

Ensembl ID : ENSSTUG00000003717
Gene Symbol: LOC115197512
3 Cross references
345 Possible Orthologues:

60s Ribosomal Protein L21

Ensembl ID : ENSSTUG00000043884
Gene Symbol: LOC115195488
3 Cross references
778 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).